The principal defect in the majority of non-insulin dependent diabetes mellitus (NIDDM) patients is impaired glycogenesis in skeletal muscle in response to insulin. Glycogen synthesis is initiated by transfer of glucosyl residues to the tyrosine OH at position 194 of a 37KD primer protein named glycogenin (1, 2) . While the enzymatic details of the first glucose addition have not yet been determined, addition of the next 8 or 9 glucose residues is autocatalytic. Subsequent elongation of this product by an enzyme named proglycogen synthase, yields an intermediate (proglycogen, M.W. 400,000) that is subsequently enlarged some 25-fold to mature glycogen of M.W. lo7 by glycogen synthase (3).
Cultured quail skeletal muscle cells, starved of glucose by incubation in glucose-free medium overnight, contained very little glycogen, ( Table 1) that was principally in the form of proglycogen. Following transfer to hyperglycemic medium (25 mM glucose), the glycogen content increased several hundred-fold within 4 hrs. This increase was stimulated by insulin ( Table 1 ). The insulin effect was not observed when the cells were pretreated for 2 hrs with dexamethasone (1 pM). Glucocorticoids also block insulin stimulation in skeletal muscle in vivQ (4). Freshly explanted quail skeletal muscle cells from 7 day embryos, were grown to confluence (10 days) in minimal Eagle medium (MEM) plus 10% serum. The medium was replaced with serum-free, glucose free medium for a further 18 hrs. Groups of triplicate cultures were incubated in MEM containing 25 mM glucose for 4 hrs with or without the addition of insulin (40 p units/ml). Dexamethasone (1 pM) when present, was added 2 h before the addition of glucose. The cells were washed with cold Tris buffer and the glycogen and protein content determined.
To determine if new glycogenin primer was being synthesized, glucose-starved cells were incubated with 25 mM glucose in the presence of cycloheximide (10 pg/ml) or actinomycin D (2 pg/ml) for 2 or 4 hrs ( Table 2) . Glycogen synthesis was not inhibited by either cycloheximide or actinomycin D indicating that the required additional glycogenin primer was being mobilized from a pre-existing pool. In cells incubated with 32P0,, insulin stimulation of glycogen synthesis was accompanied by phosphorylation of a protein having the molecular characteristics of glycogenin ( Figure 1 ). Concentrations of dexamethasone sufficient to block insulin-dependent glycogen synthesis also inhibited this phosphorylation (Figure 1 Lane 5). Suboptimal phosphorylation of this protein was also observed in similar experiments using cultured lymphocytes derived from a patient with NIDDM. 13C-NMR studies of NIDDM patients have indicated that both the rate of glycogenesis and the total glycogen content of skeletal muscle are only 50% of normal (5) . Since each glycogen particle contains a molecule of glycogenin at its core, these observations indicate that defects in the glycogenin pathway should be considered as a possible cause of NIDDM.
